237 related articles for article (PubMed ID: 30652925)
1. B cells and atherosclerosis in systemic lupus erythematosus.
Koulouri V; Koutsilieris M; Mavragani CP
Expert Rev Clin Immunol; 2019 Apr; 15(4):417-429. PubMed ID: 30652925
[TBL] [Abstract][Full Text] [Related]
2. Effects of BAFF Neutralization on Atherosclerosis Associated With Systemic Lupus Erythematosus.
Saidoune F; Even G; Lamri Y; Chezel J; Gaston AT; Escoubet B; Papo T; Charles N; Nicoletti A; Sacre K
Arthritis Rheumatol; 2021 Feb; 73(2):255-264. PubMed ID: 32783382
[TBL] [Abstract][Full Text] [Related]
3. B cell subset composition segments clinically and serologically distinct groups in chronic cutaneous lupus erythematosus.
Jenks SA; Wei C; Bugrovsky R; Hill A; Wang X; Rossi FM; Cashman K; Woodruff MC; Aspey LD; Lim SS; Bao G; Drenkard C; Sanz I
Ann Rheum Dis; 2021 Sep; 80(9):1190-1200. PubMed ID: 34083207
[TBL] [Abstract][Full Text] [Related]
4. 'That Obscure Object of Desire': in systemic lupus erythematosus B-cell activating factor/B-lymphocyte stimulator is targeted both by the immune system and by physicians.
Sanchez-Niño MD; Ortiz A
Nephrol Dial Transplant; 2015 Mar; 30(3):394-400. PubMed ID: 24914092
[TBL] [Abstract][Full Text] [Related]
5. Cutting Edge: BAFF Overexpression Reduces Atherosclerosis via TACI-Dependent B Cell Activation.
Jackson SW; Scharping NE; Jacobs HM; Wang S; Chait A; Rawlings DJ
J Immunol; 2016 Dec; 197(12):4529-4534. PubMed ID: 27837104
[TBL] [Abstract][Full Text] [Related]
6. B-cell-targeted therapy for systemic lupus erythematosus.
Sabahi R; Anolik JH
Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
[TBL] [Abstract][Full Text] [Related]
7. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
8. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
9. IFN-I Mediates Dysfunction of Endothelial Progenitor Cells in Atherosclerosis of Systemic Lupus Erythematosus.
Ding X; Xiang W; He X
Front Immunol; 2020; 11():581385. PubMed ID: 33262760
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of renal disease in systemic lupus erythematosus--the role of autoantibodies and lymphocytes subset abnormalities.
Yap DY; Lai KN
Int J Mol Sci; 2015 Apr; 16(4):7917-31. PubMed ID: 25860947
[TBL] [Abstract][Full Text] [Related]
11. B cells biology in systemic lupus erythematosus-from bench to bedside.
Zhao L; Ye Y; Zhang X
Sci China Life Sci; 2015 Nov; 58(11):1111-25. PubMed ID: 26563177
[TBL] [Abstract][Full Text] [Related]
12. The IL-12-STAT4 axis in the pathogenesis of human systemic lupus erythematosus.
Ueno H
Eur J Immunol; 2020 Jan; 50(1):10-16. PubMed ID: 31762023
[TBL] [Abstract][Full Text] [Related]
13. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
[TBL] [Abstract][Full Text] [Related]
14. Altered frequencies of memory B cells in new-onset systemic lupus erythematosus patients.
Zhu L; Yin Z; Ju B; Zhang J; Wang Y; Lv X; Hao Z; He L
Clin Rheumatol; 2018 Jan; 37(1):205-212. PubMed ID: 29067587
[TBL] [Abstract][Full Text] [Related]
15. Cytokines in systemic lupus erythematosus: far beyond Th1/Th2 dualism lupus: cytokine profiles.
Guimarães PM; Scavuzzi BM; Stadtlober NP; Franchi Santos LFDR; Lozovoy MAB; Iriyoda TMV; Costa NT; Reiche EMV; Maes M; Dichi I; Simão ANC
Immunol Cell Biol; 2017 Oct; 95(9):824-831. PubMed ID: 28649995
[TBL] [Abstract][Full Text] [Related]
16. B-cell activating factor and related genetic variants in lupus related atherosclerosis.
Theodorou E; Nezos A; Antypa E; Ioakeimidis D; Koutsilieris M; Tektonidou M; Moutsopoulos HM; Mavragani CP
J Autoimmun; 2018 Aug; 92():87-92. PubMed ID: 29859654
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid-induced leucine zipper (GILZ) inhibits B cell activation in systemic lupus erythematosus.
Jones SA; Toh AE; Odobasic D; Oudin MA; Cheng Q; Lee JP; White SJ; Russ BE; Infantino S; Light A; Tarlinton DM; Harris J; Morand EF
Ann Rheum Dis; 2016 Apr; 75(4):739-47. PubMed ID: 26612340
[TBL] [Abstract][Full Text] [Related]
18. Expanding the B Cell-Centric View of Systemic Lupus Erythematosus.
Morawski PA; Bolland S
Trends Immunol; 2017 May; 38(5):373-382. PubMed ID: 28274696
[TBL] [Abstract][Full Text] [Related]
19. Myeloid-Derived Suppressor Cells Induce the Expansion of Regulatory B Cells and Ameliorate Autoimmunity in the Sanroque Mouse Model of Systemic Lupus Erythematosus.
Park MJ; Lee SH; Kim EK; Lee EJ; Park SH; Kwok SK; Cho ML
Arthritis Rheumatol; 2016 Nov; 68(11):2717-2727. PubMed ID: 27214349
[TBL] [Abstract][Full Text] [Related]
20. Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers.
Figgett WA; Deliyanti D; Fairfax KA; Quah PS; Wilkinson-Berka JL; Mackay F
J Autoimmun; 2015 Jul; 61():9-16. PubMed ID: 26027434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
